it would appear my earlier post did not meet the requirements of the moderator.
for those interested, here it is again - and yes it is relevant
http://www.news.com.au/world/breaki...-high-tech-patch/story-e6frfkui-1227219471991
Breaking News
Heart hope from high-tech patch
3 hours ago February 14, 2015 11:50AM
SCIENTISTS are using new technology to create heart muscle patches that can be grafted on to damaged hearts and beat in response to light.
THE groundbreaking new research aims to overcome a major stumbling block in heart tissue engineering where grafted tissue does not always beat in sync with the rest of the heart.
Experts are growing heart muscle cells from stem cells which contain proteins sensitive to light, called rhodopsins.
The researchers hope that this light sensitive tissue can then be grafted on to a damaged heart, helping it beat more effectively to reduce the effects of heart failure without the risk of rhythm problems.
The work has also brought together two professors - Chris Denning from the UK and Lior Gepstein in Israel - who admit they are usually rivals.
Prof Denning, from the University of Nottingham, said: "For years, Professor Gepstein and I have been competing to be the first in our field. But this project means that instead of each team doing the same things twice, we will be co-ordinating our efforts to ensure we can help heart patients as soon as possible."
The research is being funded by the British Heart Foundation and the British Council's Britain Israel Research and Academic Exchange partnership.
"The grant ensures we can work on a very promising technique for solving one of the major challenges in regenerative medicine to mend a broken heart," Prof Denning added.
- Forums
- ASX - By Stock
- real competition?...
it would appear my earlier post did not meet the requirements of...
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 681 | $17.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.25 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 681 | 17.900 |
1 | 1 | 17.800 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
18.250 | 100 | 1 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
18.690 | 550 | 1 |
18.750 | 143 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online